end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedLiabilitiesCurrent,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts,Assets,AssetsCurrent,AssetsHeldInTrustNoncurrent,Cash,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect,CashEquivalentsAtCarryingValue,DeferredCosts,DeferredOfferingCosts,DueToRelatedPartiesCurrent,FairValueAssetsLevel1ToLevel2TransfersAmount,FairValueAssetsLevel2ToLevel1TransfersAmount,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3,GainLossOnInvestments,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsPayableRelatedParties,IncreaseDecreaseInAccountsPayableTrade,IncreaseDecreaseInAccruedLiabilities,IncreaseDecreaseInPrepaidExpensesOther,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,OperatingIncomeLoss,PaymentsForUnderwritingExpense,PaymentsOfStockIssuanceCosts,PaymentsToAcquireMarketableSecurities,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PreferredStockValue,PrepaidExpenseCurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfPrivatePlacement,ProceedsFromRelatedPartyDebt,RepaymentsOfRelatedPartyDebt,RetainedEarningsAccumulatedDeficit,StockholdersEquity,StockIssuedDuringPeriodValueIssuedForServices,StockIssuedDuringPeriodValueNewIssues,TemporaryEquityCarryingAmountAttributableToParent,UnrecognizedTaxBenefits,UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued,TemporaryEquityAccretionToRedemptionValue
2021-03-31,2021-05-13,10-Q,ARYA SCIENCES ACQUISITION CORP IV,ARYD,CIK0001838821,USD,550.0,145197.0,0.0,8734896.0,150945632.0,1430306.0,149515326.0,810094.0,810094.0,810094.0,0.0,0.0,,11071.0,0.0,0.0,0.0,0.0,15326.0,225577.0,550.0,11071.0,,71124.0,616462.0,5389318.0,150945632.0,156818.0,151069388.0,-149500000.0,-759294.0,-210251.0,-225577.0,,3386471.0,149500000.0,0.0001,1000000.0,0.0,0.0,0.0,620212.0,149500000.0,4990000.0,127075.0,161216.0,-3944110.0,-3943686.0,25000.0,149500000.0,8943690.0,0.0,0.0,
2021-06-30,2021-08-12,10-Q,ARYA SCIENCES ACQUISITION CORP IV,ARYD,CIK0001838821,USD,6500.0,178847.0,0.0,,150811733.0,1291922.0,149519811.0,757247.0,757247.0,,0.0,0.0,,0.0,0.0,0.0,,,4485.0,166913.0,,,,,,5417847.0,150811733.0,185347.0,,,,-162428.0,-166913.0,,,,0.0001,1000000.0,0.0,0.0,0.0,534675.0,,,,,-4106538.0,-4106114.0,,,9106120.0,0.0,0.0,
2021-09-30,2021-11-12,10-Q,ARYA SCIENCES ACQUISITION CORP IV,ARYD,CIK0001838821,USD,9154.0,5064797.0,0.0,,150606957.0,1074623.0,149532334.0,623637.0,623637.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,12523.0,5105903.0,,,,,,10306451.0,150606957.0,5073951.0,,,,-5093380.0,-5105903.0,,,,0.0001,1000000.0,0.0,0.0,0.0,450986.0,,,,,-9199918.0,-9199494.0,,,149500000.0,0.0,0.0,
